AZD6234
A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD6234 After Repeat Dose Administration in Participants Who Are Overweight or Obese
AstraZeneca · Phase 1 · Completed · Enrollment 104
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| Cohort 1 | Healthy Participants | n/r | n/r | n/r | n/r |
| Cohort 2 | Healthy Participants | n/r | n/r | n/r | n/r |
| Cohort 3 | Healthy Participants | n/r | n/r | n/r | n/r |
| Cohort 4 | Healthy Participants | n/r | n/r | n/r | n/r |